News & views

A collection of stories about our people, our research, and global health.

Browse all news

Logo for International Safe Abortion Day

10 min read

Safe abortion day 2026

This International Safe Abortion Day, we're looking at a dimension of the abortion conversation that rarely receives attention: R&D. Abortion is a common part of reproductive life worldwide, yet R&D funding for it has fallen sharply and rests almost entirely on a single funder. Our latest analysis unpacks the gaps in the product pipeline and what "solidarity in action" should mean for abortion R&D.

Emily SmithEmily Smith25 Sept 2026
NIH Mark O. Hatfield Clinical Research Center, Bethesda, Maryland

5 min read

What the NIH cuts mean for global health - an update

An update on the impact on global health R&D of the cuts to the NIH and underlying changes to the grantmaking process.

Dr Paul BarnsleyDr Paul Barnsley25 Sept 2026
Photo of contraceptive choices

10 min read

A choice for all? What seven years of contraceptive, MPT and abortion R&D funding says about agency, intention and access

We analyse seven years of contraceptive, MPT and abortion R&D funding to understand what it tells us about agency, intention and access.

Emily SmithEmily Smith24 Sept 2026
Biohazard sign

5 min read

Assessing funding for biosafety and biosecurity

We're working with CEPI to examine how biosafety and biosecurity are funded in global health R&D. We invite partners to fill in this short survey to provide us with their views and experience.

Harriet BellImpact Global Health 26 Aug 2026
Ripple effect 3.0 image

2 min read

The Ripple Effect 3.0

The third iteration of Impact Global Health's 'ripple effect' research provides five new case studies to deepen the evidence base for the domestic benefits of global health R&D.

Harriet BellImpact Global Health 18 June 2026
Image of the G-FINDER portal landing page

5 min read

No data, no direction

Lis Oversteegen reveals how the G-FINDER survey turns funding data into the insights that drive smarter global health investment.

Lisette OversteegenLisette Oversteegen3 June 2026
Ebola virus - Photo by National Institute of Allergy and Infectious Diseases

5 min read

How ‘boom and bust’ Ebola R&D funding leaves us vulnerable

We conducted a deep dive to better understand why there remains such a limited set of tools for the current Bundibugyo strain outbreak in the DRC.

Harriet BellImpact Global Health 29 May 2026
Malaria No More image for press release with credit

5 min read

UK backs one in five malaria tools in development - as campaigners warn “malaria science superpower” status must be maintained

New research shows UK institutions are involved in R&D for 20% of malaria tools currently in the pipeline – the third highest of any country

Harriet BellImpact Global Health 25 Apr 2026
Pipeline visual for article overview

5 min read

Our Pipeline Portal: from data to decisions in global health R&D

We’re excited to introduce our new Product Pipeline portal, a single, easy-to-use tool that brings together all our data on both candidates and approved products. Learn more from Dr. Vipul Chowdhary, our Technical Lead, on how this resource can support your work.

Harriet BellDr Vipul Chowdhary30 Mar 2026
...